The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 13, 2019
Filed:
Apr. 24, 2018
Applicant:
Medtronic Ardian Luxembourg S.a.r.l., Luxembourg, LU;
Inventors:
Mark Gelfand, New York, NY (US);
Howard R. Levin, Teaneck, NJ (US);
Assignee:
Medtronic Ardian Luxembourg S.a.r.l., Luxembourg, LU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/32 (2006.01); A61N 1/36 (2006.01); A61N 1/05 (2006.01); A61N 1/362 (2006.01); A61K 31/529 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61L 29/14 (2006.01); A61M 5/145 (2006.01); A61K 31/135 (2006.01); A61K 31/52 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/529 (2013.01); A61K 9/0004 (2013.01); A61K 9/0012 (2013.01); A61K 9/7007 (2013.01); A61K 31/135 (2013.01); A61K 31/52 (2013.01); A61K 45/06 (2013.01); A61L 29/146 (2013.01); A61M 5/145 (2013.01); A61M 5/14276 (2013.01); A61M 5/1723 (2013.01); A61N 1/326 (2013.01); A61N 1/36114 (2013.01); A61M 2005/14513 (2013.01); A61M 2205/05 (2013.01); A61M 2205/50 (2013.01); A61M 2210/1082 (2013.01); A61N 1/0551 (2013.01); A61N 1/36007 (2013.01); A61N 1/3627 (2013.01); A61N 1/36117 (2013.01);
Abstract
Methods for treating a hypertensive human patient are disclosed herein. A method in accordance with one embodiment comprises delivering a neuromodulatory agent to a renal nerve of the patient via an intravascularly positioned drug delivery catheter. The method includes at least partially blocking neural activity along the renal nerve with the neuromodulatory agent, which results in a therapeutically beneficial reduction in blood pressure of the patient.